Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

Testimonials

society alike – values which Celgene strive to achieve. ... Lisa McCurdy, Associate Director - Haematology, Celgene. “You never forget that feeling of being a winner and of knowing that you are at the very top of your profession – it means that

FDA approves Amgen’s Otezla for all patients with plaque psoriasis

FDA approves Amgen’s Otezla for all patients with plaque psoriasis Celgene’s top psoriasis drug, Otezla (apremilast), which was raking in $1.6bn a year and growing fast, clashed with one of BMS' most promising molecules, deucravacitinib. ... As it became clear that anti-competition regulators would balk at BMS owning

Merck to acquire Acceleron in a deal worth around $11.5bn

Merck to acquire Acceleron in a deal worth around $11.5bn The drug is part of a long-standing global collaboration with Celgene, now part of Bristol Myers Squibb (BMS).

Mysterious big pharma company eyes US biotech Acceleron

Mysterious big pharma company eyes US biotech Acceleron The drug is part of a long-standing global collaboration with Celgene, now part of Bristol Myers Squibb (BMS).

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug The FDA approved Sarclisa for the treatment of patients with relapsed or refractor multiple myeloma who have received at least two prior therapies, including Celgene’s Revlimid (lenalidomide) and a proteasome

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...